GERN
Biotechnology · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when Geron Corp publishes a filing, an earnings call transcript or a press release.
Get GERN alertsGeron Corp reported in an 8-K filed October 14, 2025 that Ahmed ElNawawi was appointed Executive Vice President, Chief Commercial Officer, effective October 20, 2025. The proxy statement of Geron Corp reports total compensation of $2,881,334 for Ahmed ElNawawi in fiscal 2025, including a base salary of $107,692. Ahmed ElNawawi has spoken on 3 earnings calls across 1 company, most recently for Geron Corp on November 4, 2026. Geron Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Geron Corp includes Elizabeth G. O'Farrell (Chairman and Board Member), Michelle J. Robertson (CFO), Shanthakumar Tyavanagimatt (CTO) and 7 others.
“Succeeding Jim, Ahmed ElNawawi (“Nawawi”) has been appointed Executive Vice President, Chief Commercial Officer, effective October 20, 2025.”
“We are pleased to report our fourth consecutive quarter of demand growth for Rytelo, reinforcing the need for this drug and its potential long-term value as a preferred treatment in second-line low-risk MDS.”
“We delivered solid Ritello net revenue growth in the second quarter, marking our third straight quarter of demand growth and continued to execute on our commercial strategy to build sustainable growth and long-term value.”
“Ritello's first quarter performance was in crisis. Our strategy is built to support sustainable growth and ensure Ritello reaches more eligible patients at the right point in their treatment period, when they are most likely to benefit.”
Source not stated
GERN
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Geron Corp (GERN) | Executive Vice President, Chief Commercial Officer (as of October 20, 2025) | $107,692 | $2,881,334 |